255 related articles for article (PubMed ID: 32642818)
1. [Quality of indications in cystic lesions of the pancreas].
Renz BW; Ilmer M; D'Haese JG; Werner J
Chirurg; 2020 Sep; 91(9):736-742. PubMed ID: 32642818
[TBL] [Abstract][Full Text] [Related]
2. Management of branch-duct intraductal papillary mucinous neoplasms: a large single-center study to assess predictors of malignancy and long-term outcomes.
Ridtitid W; DeWitt JM; Schmidt CM; Roch A; Stuart JS; Sherman S; Al-Haddad MA
Gastrointest Endosc; 2016 Sep; 84(3):436-45. PubMed ID: 26905937
[TBL] [Abstract][Full Text] [Related]
3. MUC2 expression and prevalence of high-grade dysplasia and invasive carcinoma in mixed-type intraductal papillary mucinous neoplasm of the pancreas.
Masuda A; Arisaka Y; Hara S; Matsumoto I; Takenaka M; Sakai A; Shiomi H; Matsuki N; Sugimoto M; Fujita T; Hayakumo T; Ku Y; Ogino S; Azuma T; Kutsumi H
Pancreatology; 2013; 13(6):583-8. PubMed ID: 24280573
[TBL] [Abstract][Full Text] [Related]
4. Surgery of Cystic Tumors of the Pancreas - Why, When, and How?
D'Haese JG; Werner J
Visc Med; 2018 Jul; 34(3):206-210. PubMed ID: 30182025
[TBL] [Abstract][Full Text] [Related]
5. The role of endoscopic ultrasound in the management of intraductal papillary mucinous neoplasms.
Smith LA; Mckay CJ
Minerva Med; 2014 Oct; 105(5):413-21. PubMed ID: 25000220
[TBL] [Abstract][Full Text] [Related]
6. The Role of Endoscopic Ultrasound in the Diagnosis of Cystic Lesions of the Pancreas.
Lévy P; Rebours V
Visc Med; 2018 Jul; 34(3):192-196. PubMed ID: 30140684
[TBL] [Abstract][Full Text] [Related]
7. The role of endoscopic ultrasound in the management of intraductal papillary mucinous neoplasms: a systematic update.
Smith LA; McKay CJ
Minerva Med; 2016 Dec; 107(6):370-380. PubMed ID: 27627636
[TBL] [Abstract][Full Text] [Related]
8. Approach to cystic lesions of the pancreas.
Schmid RM; Siveke JT
Wien Med Wochenschr; 2014 Feb; 164(3-4):44-50. PubMed ID: 24254128
[TBL] [Abstract][Full Text] [Related]
9. [Intraductal papillary mucinous neoplasm of the pancreas (IPMN)--standards and new aspects].
Distler M; Welsch T; Aust D; Weitz J; Grützmann R
Zentralbl Chir; 2014 Jun; 139(3):308-17. PubMed ID: 24241954
[TBL] [Abstract][Full Text] [Related]
10. [Cystic pancreatic tumors: diagnostics and new biomarkers].
Berger AW; Seufferlein T; Kleger A
Chirurg; 2017 Nov; 88(11):905-912. PubMed ID: 28831506
[TBL] [Abstract][Full Text] [Related]
11. A large multicenter study of recurrence after surgical resection of branch-duct intraductal papillary mucinous neoplasm of the pancreas.
Yan L; Siddiqui AA; Laique SN; Saumoy M; Kahaleh M; Yoo J; Kalra A; Mathew A; Sterling J; Rao R; Lieberman M; Cosgrove N; Sharaiha RZ
Minerva Gastroenterol Dietol; 2017 Mar; 63(1):50-54. PubMed ID: 27824244
[TBL] [Abstract][Full Text] [Related]
12. Uptodate in the assessment and management of intraductal papillary mucinous neoplasms of the pancreas.
Pagliari D; Saviano A; Serricchio ML; Dal Lago AA; Brizi MG; Lanza F; Manfredi R; Gasbarrini A; Attili F
Eur Rev Med Pharmacol Sci; 2017 Jun; 21(12):2858-2874. PubMed ID: 28682431
[TBL] [Abstract][Full Text] [Related]
13. [Cystic lesions of the pancreas : Differential diagnostics and treatment].
Rosendahl J; Michl P
Internist (Berl); 2019 Mar; 60(3):219-225. PubMed ID: 30617702
[TBL] [Abstract][Full Text] [Related]
14. Pancreatic Cystic Neoplasms: Different Types, Different Management, New Guidelines.
Scholten L; van Huijgevoort NCM; van Hooft JE; Besselink MG; Del Chiaro M
Visc Med; 2018 Jul; 34(3):173-177. PubMed ID: 30182024
[TBL] [Abstract][Full Text] [Related]
15. [Branch duct intraductal papillary mucinous neoplasm - contra resection].
Brunner M; Weber GF; Kersting S; Grützmann R
Chirurg; 2017 Nov; 88(11):918-926. PubMed ID: 28871376
[TBL] [Abstract][Full Text] [Related]
16. [Indications for the Surgical Management of Pancreatic Cystic Lesions].
Brunner M; Belyaev O; Bösch F; Müller-Debus CF; Radulova-Mauersberger O; Wellner UF; Keck T; Uhl W; Werner J; Witzigmann H; Grützmann R
Zentralbl Chir; 2020 Aug; 145(4):344-353. PubMed ID: 32498095
[TBL] [Abstract][Full Text] [Related]
17. Imaging considerations in intraductal papillary mucinous neoplasms of the pancreas.
Pedrosa I; Boparai D
World J Gastrointest Surg; 2010 Oct; 2(10):324-30. PubMed ID: 21160838
[TBL] [Abstract][Full Text] [Related]
18. Thirty years of experience with intraductal papillary mucinous neoplasm of the pancreas: from discovery to international consensus.
Tanaka M
Digestion; 2014; 90(4):265-72. PubMed ID: 25591885
[TBL] [Abstract][Full Text] [Related]
19. Pancreatic main-duct involvement in branch-duct IPMNs: an underestimated risk.
Fritz S; Klauss M; Bergmann F; Strobel O; Schneider L; Werner J; Hackert T; Büchler MW
Ann Surg; 2014 Nov; 260(5):848-55; discussion 855-6. PubMed ID: 25379856
[TBL] [Abstract][Full Text] [Related]
20. Long-term Risk of Pancreatic Malignancy in Patients With Branch Duct Intraductal Papillary Mucinous Neoplasm in a Referral Center.
Pergolini I; Sahora K; Ferrone CR; Morales-Oyarvide V; Wolpin BM; Mucci LA; Brugge WR; Mino-Kenudson M; Patino M; Sahani DV; Warshaw AL; Lillemoe KD; Fernández-Del Castillo C
Gastroenterology; 2017 Nov; 153(5):1284-1294.e1. PubMed ID: 28739282
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
